Missed the webinar? Here are Investing.com’s top 10 stock picks for 2026
Clearmind Medicine Inc. (NASDAQ:CMND) announced Friday that it will hold its Annual and Special Meeting of Shareholders on Monday, December 29, 2025. The company’s board of directors has set November 20, 2025, as the record date for determining shareholders eligible to receive notice of and vote at the meeting.
According to a press release statement filed with the Securities and Exchange Commission, proxy materials for the meeting have been made available to shareholders. The filing includes a management information circular, a form of proxy card, a voting instruction form, and a financial statements request form.
Clearmind Medicine, a pharmaceutical company headquartered in Vancouver, British Columbia, stated that the meeting will address both annual and special matters, although specific agenda items were not detailed in the filing.
The information is based on a statement included in the company’s recent SEC filing.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
